Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer
Oncogene (2023) - Comment
pubmed: 36596844  doi: 10.1038/s41388-022-02566-6  issn: 0950-9232  issn: 1476-5594 

Joy C. Yang, Pengfei Xu, Shu Ning, Logan J. Wasielewski, Hans Adomat, Sung Hee Hwang, Christophe Morisseau, Martin Gleave, Eva Corey, Allen C. Gao, Primo N. Lara Jr, Christopher P. Evans, Bruce D. Hammock, Chengfei Liu